Figure (Image 01)
Myorisan
Product Images NDC 61748-304
8 FDA label images from Akorn Operating Company Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Myorisan (NDC 61748-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Akorn Operating Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Image 02)
Chemical structure of the active ingredient in Myorisan, depicting a molecule with a cyclohexene ring, a polyene chain, and a carboxylic acid group.*
Versapharm Logo (Image 03)
Principal Display Panel (10 mg Prescription Blister Pack)
Myorisan 10 mg (isotretinoin USP) capsule blister pack label by Akorn Operating Company LLC. The label highlights serious birth defects warnings, patient information, and special instructions for pregnant patients or those who can get pregnant. It includes detailed safety precautions, side effects to watch for, and instructions for use and storage.*
Principal Display Panel (20 mg Prescription Blister Pack)
Myorisan 20 mg (isotretinoin capsules) packaging label by Akorn Operating Company LLC. The label displays safety warnings highlighting the risks of serious birth defects, warnings for patients who can get pregnant, and important patient information. It includes instructions for use, storage conditions, and advice to read the Medication Guide. The packaging shows a 10-capsule prescription pack.*
Principal Display Panel (30 mg Prescription Blister Pack)
Myorisan 30 mg (isotretinoin capsules, USP) packaging label from Akorn Operating Company LLC. The label includes warnings about serious birth defects, a barcode, patient information, and detailed safety information for patients who can get pregnant. The packaging also shows 10 capsule-shaped perforated dose compartments with several patient warnings about pregnancy prevention and side effects.*
Principal Display Panel (40 mg Prescription Blister Pack)
Myorisan 40 mg Prescription Capsule packaging label by Akorn Operating Company LLC. The label prominently highlights warnings about severe birth defects and strict precautions for patients who can get pregnant. It includes detailed patient instructions regarding use, side effects, and the importance of following a Medication Guide. The label also displays the package contains 10 capsules.*
Image 08
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
